Publication and Disclosure 5 Sample Clauses

Publication and Disclosure 5. 1. Publikování a zpřístupnění Institution and Investigator shall have the right to publish or present the results of Institution’s and Investigator’s activities conducted under this Agreement, including Study Data, only in accordance with the requirements of this Section. Institution and Investigator agree to submit any proposed publication or presentation to Sponsor for review at least sixty (60) days prior to submitting any such proposed publication to a publisher or proceeding with such proposed presentation. Within sixty (60) days of its receipt, Sponsor shall advise Institution and/or Investigator, as the case may be, in writing of any information contained therein which is Confidential Information (other than Study Data) or which may impair the availability of patent protection for Inventions. Sponsor shall have the right to require Institution and/or Investigator, as applicable, to remove specifically identified Confidential Information (other than Study Data) and/or to delay the proposed publication or presentation for an additional sixty (60) days to enable Sponsor to seek patent protection for Inventions. Zdravotnické zařízení a Zkoušející budou oprávněni publikovat a prezentovat výsledky činnosti Instituce a Zkoušejícího, jež je prováděná na základě této Smlouvy, a to včetně Studijních dat a údajů, výlučně v souladu s požadavky stanovenými v tomto Článku. Zdravotnické zařízení a Zkoušející souhlasí, že Zadavateli předloží jakoukoli navrhovanou publikaci a prezentaci pro účely jejich kontroly ve lhůtě alespoň šedesáti (60) dnů před předložením jakékoli takové publikace příslušnému vydavateli či před jejich navrhovanou prezentací. Ve lhůtě šedesáti (60) dnů od jejich přijetí, Zadavatel se písemně vyjádří Zdravotnickému zařízení a/nebo Zkoušejícímu, vždy dle podmínek konkrétního případu, ve vztahu k jakékoli informaci obsažené v takových materiálech, jež představuje Důvěrnou informaci (odlišnou od Studijních dat a údajů) nebo jež může představovat překážku možnosti dosažení patentové ochrany příslušného Objevu. Zadavatel bude oprávněn požadovat vůči Zdravotnickému zařízení a/nebo Zadavateli, vždy dle podmínek konkrétního případu, odstranění definovaných informací označených jako Důvěrné informace (jež jsou odlišné od Studijních dat a údajů) a/nebo požadovat odložení navrhované publikace či prezentace po dobu dodatečných šedesáti (60) dnů, aby umožnil Zadavateli uplatnění patentové ochrany ve vztahu k takovému Objevu.
AutoNDA by SimpleDocs
Publication and Disclosure 5. 1 Publikování a zpřístupnění Institution and Investigator shall have the right to publish or present the results of Institution’s and Investigator’s activities conducted under this Agreement, including Study Data, only in accordance with the requirements of this Section. Institution and Investigator agree to submit any proposed publication or presentation to Sponsor for review at least thirty (30) days prior to submitting any such proposed publication to a publisher or proceeding with such proposed presentation. Within thirty (30) days of its receipt, Sponsor shall advise Institution and/or Investigator, as the case may be, in writing of any Poskytovatel a Zkoušející budou oprávněni publikovat a prezentovat výsledky činnosti Poskytovatele a Zkoušejícího, jež je prováděná na základě této Smlouvy, a to včetně Studijních dat a údajů, výlučně v souladu s požadavky stanovenými v tomto Článku. Poskytovatel a Zkoušející souhlasí, že Xxxxxxxxxx předloží jakoukoli navrhovanou publikaci a prezentaci pro účely jejich kontroly ve lhůtě alespoň třiceti
Publication and Disclosure 5. 1. Publikování a zpřístupnění Institution and Investigator shall have the right to publish or present the results of Institution’s and Investigator’s activities conducted under this Agreement, including Study Data, only in accordance with the requirements of this Section. All publications or presentations relating to this Agreement, the Study or data derived from this Study will be submitted to the Sponsor prior to any submission or presentation and Sponsor will approve all Publications in writing. Zdravotnické zařízení a Zkoušející budou oprávněni publikovat a prezentovat výsledky činnosti Instituce a Zkoušejícího, jež je prováděná na základě této Smlouvy, a to včetně Studijních dat a údajů, výlučně v souladu s požadavky stanovenými v tomto Článku. Veškeré publikace nebo prezentace související s touto Smlouvou, Studií nebo údaji odvozenými z této Studie musí být předloženy Zadavateli před jejich předložením k vydání nebo prezentováním a Zadavatel bude všechny Publikace schvalovat písemně.
Publication and Disclosure 5. 1. Publikování a zpřístupnění Institution and Investigator shall have the right to publish or present the results of Institution’s and Investigator’s activities conducted under this Agreement, including Study Data, only in accordance with the requirements of this Section. Institution and Investigator agree to submit any proposed publication or presentation to Sponsor for review and comments at least thirty (30) days prior to submitting any such proposed publication to a publisher or proceeding with such proposed presentation. Within thirty

Related to Publication and Disclosure 5

  • Use and Disclosure All Confidential Information of a party will be held in confidence by the other party with at least the same degree of care as such party protects its own confidential or proprietary information of like kind and import, but not less than a reasonable degree of care. Neither party will disclose in any manner Confidential Information of the other party in any form to any person or entity without the other party’s prior consent. However, each party may disclose relevant aspects of the other party’s Confidential Information to its officers, affiliates, agents, subcontractors and employees to the extent reasonably necessary to perform its duties and obligations under this Agreement and such disclosure is not prohibited by applicable law. Without limiting the foregoing, each party will implement physical and other security measures and controls designed to protect (a) the security and confidentiality of Confidential Information; (b) against any threats or hazards to the security and integrity of Confidential Information; and (c) against any unauthorized access to or use of Confidential Information. To the extent that a party delegates any duties and responsibilities under this Agreement to an agent or other subcontractor, the party ensures that such agent and subcontractor are contractually bound to confidentiality terms consistent with the terms of this Section 11.

  • AGREEMENTS AND DISCLOSURES The Agreements and Disclosures provided to You at the time You opened Your Account and referred to throughout this Agreement, contain: (a) a list of fees and charges applicable to Your Account;

  • UPDATING AND DISCLOSING FINANCIAL INFORMATION You will provide facts to update information contained in Your original Account application or other financial information related to You, at Our request. You also agree that We may, from time to time, as We deem necessary, make inquiries pertaining to Your employment, credit standing and financial responsibility in accordance with applicable laws and regulations. You further agree that We may give information about the status and payment history of Your Account to consumer credit reporting agencies, a prospective employer or insurer, or a state or federal licensing agency having any apparent legitimate business need for such information.

  • Uses and Disclosures Pursuant to the terms of this Agreement, Contractor may receive from the Exchange Protected Health Information and/or Personally Identifiable Information in connection with Contractor Exchange Functions that is protected under applicable Federal and State laws and regulations. Contractor shall not use or disclose such Protected Health Information or Personally Identifiable Information obtained in connection with Contractor Exchange Functions other than as is expressly permitted under the Exchange Requirements and only to the extent necessary to perform the functions called for within this Agreement.

  • Identification and Disclosure of Privacy and Security Offices Business Associate and Subcontractors shall provide, within ten (10) days of the execution of this agreement, written notice to the Covered Entity’s contract/grant manager the names and contact information of both the HIPAA Privacy Officer and HIPAA Security Officer. This information must be updated any time either of these contacts changes.

  • Confidentiality and Disclosure The Local Manager and the Investment Adviser undertake to keep private and confidential all information acquired in connection with this Agreement, and not to disclose such information to any person except to the extent that:

  • Use and Disclosure of PHI Business Associate is limited to the following permitted and required uses or disclosures of PHI:

  • Records Audit and Disclosure 5.01 Access to records, books, and documents In addition to any right of access arising by operation of law, Performing Agency and any of Performing Agency’s affiliate or subsidiary organizations, or Subcontractors shall permit the System Agency or any of its duly authorized representatives, as well as duly authorized federal, state or local authorities, unrestricted access to and the right to examine any site where business is conducted or Services are performed, and all records, which includes but is not limited to financial, client and patient records, books, papers or documents related to this Contract. If the Contract includes federal funds, federal agencies that shall have a right of access to records as described in this section include: the federal agency providing the funds, the Comptroller General of the United States, the General Accounting Office, the Office of the Inspector General, and any of their authorized representatives. In addition, agencies of the State of Texas that shall have a right of access to records as described in this section include: the System Agency, HHSC, HHSC's contracted examiners, the State Auditor’s Office, the Texas Attorney General's Office, and any successor agencies. Each of these entities may be a duly authorized authority. If deemed necessary by the System Agency or any duly authorized authority, for the purpose of investigation or hearing, Performing Agency shall produce original documents related to this Contract. The System Agency and any duly authorized authority shall have the right to audit xxxxxxxx both before and after payment, and all documentation that substantiates the xxxxxxxx. Performing Agency shall include this provision concerning the right of access to, and examination of, sites and information related to this Contract in any Subcontract it awards.

  • NOTICES AND DISCLOSURES Behavioral HealthCare Parity This plan provides parity in benefits for behavioral health services. This means that coverage of benefits for mental health and substance use disorders is generally comparable to, and not more restrictive than, the benefits for physical health. Financial requirements, such as deductibles, copayments, or benefit limits that may apply to a behavioral health service benefit category, such as inpatient services, are not more restrictive than those that apply to most medical benefits within the same category. Different levels of financial requirements to different tiers of prescription drugs are applied without regard to whether a prescription drug is generally prescribed for physical, mental health, or substance use disorders. Other requirements are imposed that are not expressed numerically, such as preauthorization, concurrent utilization review, and retrospective utilization review. These are applied to behavioral health services in comparable ways as medical benefits.

  • Specific Use and Disclosure Provisions (A) Except as otherwise limited in this Section of the Contract, Business Associate may use PHI for the proper management and administration of Business Associate or to carry out the legal responsibilities of Business Associate.

Time is Money Join Law Insider Premium to draft better contracts faster.